相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA)
Rana Rais et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test
Karolina J. Janczura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model
Fabia Febbraro et al.
EXPERIMENTAL NEUROLOGY (2013)
Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease
Chuang Guo et al.
NEUROBIOLOGY OF AGING (2013)
Pharmacokinetics and Pharmacodynamics of the Glutamate Carboxypeptidase II Inhibitor 2-MPPA Show Prolonged Alleviation of Neuropathic Pain through an Indirect Mechanism
James J. Vornov et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Intranasal delivery of biologics to the central nervous system
Jeffrey J. Lochhead et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
C. Barinka et al.
CURRENT MEDICINAL CHEMISTRY (2012)
The Role of Glutamate Signaling in Pain Processes and its Regulation by GCP II Inhibition
K. M. Wozniak et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Radiofluorinated Derivatives of 2-(Phosphonomethyl)pentanedioic Acid as Inhibitors of Prostate Specific Membrane Antigen (PSMA) for the Imaging of Prostate Cancer
Keith Graham et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis
Kristen A. Rahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
mGluR3 and not mGluR2 receptors mediate the efficacy of NAAG peptidase inhibitor in validated model of schizophrenia
Rafal T. Olszewski et al.
SCHIZOPHRENIA RESEARCH (2012)
Reversible Disulfide Formation of the Glutamate Carboxypeptidase II Inhibitor E2072 Results in Prolonged Systemic Exposures In Vivo
Rana Rais et al.
DRUG METABOLISM AND DISPOSITION (2012)
Systemic and Direct Nose-to-Brain Transport Pharmacokinetic Model for Remoxipride after Intravenous and Intranasal Administration
Jasper Stevens et al.
DRUG METABOLISM AND DISPOSITION (2011)
N-Acetylaspartylglutamate is an agonist at mGluR3 in vivo and in vitro
Joseph H. Neale
JOURNAL OF NEUROCHEMISTRY (2011)
Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism
Zheng-Xiong Xi et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Intranasal Delivery to the Central Nervous System: Mechanisms and Experimental Considerations
Shyeilla V. Dhuria et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model
Mary O. Adedoyin et al.
MOLECULAR PAIN (2010)
Trigeminal Pathways Deliver a Low Molecular Weight Drug from the Nose to the Brain and Orofacial Structures
Neil J. Johnson et al.
MOLECULAR PHARMACEUTICS (2010)
N-acetylaspartylglutamate (NAAG) inhibits intravenous cocaine self-administration and cocaine-enhanced brain-stimulation reward in rats
Zheng-Xiong Xi et al.
NEUROPHARMACOLOGY (2010)
Glutamate Carboxypeptidase Inhibition Reduces the Severity of Chemotherapy-Induced Peripheral Neurotoxicity in Rat
Valentina A. Carozzi et al.
NEUROTOXICITY RESEARCH (2010)
Intranasal Drug Targeting of Hypocretin-1 (Orexin-A) to the Central Nervous System
Shyeilla V. Dhuria et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Delivery of Nerve Growth Factor to Brain Via Intranasal Administration and Enhancement of Brain Uptake
Siva Ram Kiran Vaka et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke
Leah R. Hanson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
The Neuroactive Peptide N-Acetylaspartylglutamate Is Not an Agonist at the Metabotropic Glutamate Receptor Subtype 3 of Metabotropic Glutamate Receptor
Maninder Chopra et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Children With Autism Demonstrate Circumscribed Attention During Passive Viewing of Complex Social and Nonsocial Picture Arrays
Noah J. Sasson et al.
AUTISM RESEARCH (2008)
Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain
Tatsuo Yamamoto et al.
MOLECULAR PAIN (2008)
Delivery of interferon-β to the monkey nervous system following intranasal administration
R. G. Thorne et al.
NEUROSCIENCE (2008)
Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats
Tatsuo Yamamoto et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration
Jens Nagel et al.
NEUROPHARMACOLOGY (2006)
The preventive and therapeutic effects of GCPIl (NAALADase) inhibition on painful and sensory diabetic neuropathy
W. Zhang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat
C Zhong et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer
JR Mesters et al.
EMBO JOURNAL (2006)
2-Phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice
JJ Luszczki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury
DJ Bacich et al.
JOURNAL OF NEUROCHEMISTRY (2005)
The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693
JP van der Post et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Radiolabeled small-molecule ligands for prostate-specific membrane antigen:: In vivo imaging in experimental models of prostate cancer
CA Foss et al.
CLINICAL CANCER RESEARCH (2005)
NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats
CL Zhong et al.
JOURNAL OF NEUROTRAUMA (2005)
Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats
JB Long et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3
A Berent-Spillson et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: Efficacy as analgesic agents
AP Kozikowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model
T Yamamoto et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration
RG Thorne et al.
NEUROSCIENCE (2004)
NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR
RT Olszewski et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat
KJ Carpenter et al.
NEUROPEPTIDES (2003)
Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models
GD Ghadge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-Cell responses in animals and humans
J Farrell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA
P Popik et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Nasal drug delivery - possibilities, problems and solutions
L Illum
JOURNAL OF CONTROLLED RELEASE (2003)
Nasal drug delivery: new developments and strategies
L Illum
DRUG DISCOVERY TODAY (2002)
Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay
C Rojas et al.
ANALYTICAL BIOCHEMISTRY (2002)
NAALADase (GCP II) inhibition prevents cocaine-kindled seizures
JM Witkin et al.
NEUROPHARMACOLOGY (2002)
Synthesis and biological evaluation of (R)- and (S)-2-(phosphonomethyl)pentanedioic acids as inhibitors of glutamate carboxypeptidase II
D Vitharana et al.
TETRAHEDRON-ASYMMETRY (2002)
GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats
W Zhang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2002)
Effect of 2-(phosphono-methyl)-pentanedioic acid on allodynia and afferent ectopic discharges in a rat model of neuropathic pain
SR Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Design and pharmacological activity of phosphinic acid based NAALADase inhibitors
PF Jackson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Spinal N-acetyl-α-linked acidic dipeptidase (NAALADase) inhibition attenuates mechanical allodynia induced by paw carrageenan injection in the rat
T Yamamoto et al.
BRAIN RESEARCH (2001)
Inhibition of spinal N-acetylated-alpha-linked acidic dipeptidase produces an antinociceptive effect in the rat formalin test
T Yamamoto et al.
NEUROSCIENCE (2001)
NAALADase inhibition reduces alcohol consumption in the alcohol-preferring (P) line of rats
DL McKinzie et al.
ADDICTION BIOLOGY (2000)
Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons
FC Tortella et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
N-acetylaspartylglutamate:: The most abundant peptide neurotransmitter in the mammalian central nervous system
JH Neale et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
